India’s biopharma leap is gaining momentum as peptides and ADCs drive investment, advanced therapeutics, precision diagnostics and manufacturing growth.
India’s Drug Pricing Architecture is evolving as regulators expand price controls, compliance rules, and reforms to improve medicine affordability.
Pharma giants are locking in drug discovery platforms, oral small molecules, radiopharmaceuticals, and manufacturing networks to strengthen future pipelines.
Severe headache, fever, confusion, and neck stiffness can signal meningitis. On World Meningitis Day 2026, experts explain warning signs and when urgent medical care is needed.
Lixudebart is CSL and Alentis USD 1.6 billion bet on claudin-1, spanning rare kidney diseases and the unmet treatment need in PSC.
Cancer care is entering a new phase as blood-based detection and drug combinations create new paths for earlier diagnosis and stronger treatment.
Engineered LC3 could make autophagy more programmable, giving researchers greater control over the cell-cleansing pathway. The CSIR-IGIB-led study explores its potential as a therapeutic platform for cancer and neurodegenerative diseases.
Long-acting immunology antibodies are central to Sanofi and Regeneron's expanded alliance, with USD 1 billion upfront and up to USD 7 billion in milestones as they build beyond Dupixent.
Lilly and Novo intensify the weight loss and diabetes market battle with new efficacy, oral drug, and cardiovascular data.
World Heart Day 2026 highlights eight practical ways to protect heart health through daily habits, timely screening and specialised care.
.jpg)
, CDSCO.jpg)
